NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.47M | 60.07M | 56.91M | 53.63M | 53.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.47M | 60.07M | 56.91M | 53.63M | 53.13M |
| Cost of Revenue | 50.58M | 48.51M | 46.05M | 43.38M | 43.02M |
| Gross Profit | 11.89M | 11.57M | 10.87M | 10.25M | 10.11M |
| SG&A Expenses | 8.79M | 8.25M | 7.78M | 7.42M | 7.41M |
| Depreciation & Amortization | 1.64M | 1.66M | 1.67M | 1.66M | 1.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.01M | 58.41M | 55.50M | 52.46M | 52.10M |
| Operating Income | 1.46M | 1.66M | 1.41M | 1.17M | 1.03M |
| Income Before Tax | -33.90K | 135.00K | -81.90K | -123.30K | -201.00K |
| Income Tax Expenses | 254.50K | 312.50K | 264.20K | 205.40K | 155.00K |
| Earnings from Continuing Operations | -0.29 | -0.18 | -0.35 | -0.33 | -0.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -217.20K | -209.80K | -224.20K | -211.70K | -177.00K |
| Net Income | -505.80K | -387.40K | -570.30K | -540.50K | -533.10K |
| EBIT | 1.46M | 1.66M | 1.41M | 1.17M | 1.03M |
| EBITDA | 3.29M | 3.08M | 2.85M | 2.59M | 2.47M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 225.45M | 225.64M | 225.58M | 225.32M | 225.40M |
| Average Diluted Shares Outstanding | 229.80M | 229.99M | 228.12M | 226.64M | 225.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |